We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Imaging Reveals Calcified Plaque in Arteries May Pose Dementia, Stroke Risk

By HospiMedica International staff writers
Posted on 06 Sep 2011
Greater calcium build-up in the blood vessels outside the brain may be associated with brain changes associated with the future risk of dementia and stroke, according to new research.

The study’s findings were published online August 25, 2011, in the journal Arteriosclerosis, Thrombosis and Vascular Biology. “The relationship between calcium in atherosclerotic plaque and brain changes exists on top of the effect of classic cardiovascular risk factors such as high blood pressure, smoking, and diabetes,” said Meike W. More...
Vernooij, MD, PhD, senior study author and assistant professor of epidemiology and radiology at the Erasmus Medical Center (Rotterdam, The Netherlands).

Furthermore, the amount of hardened, calcified plaque provided more data about the extent of brain changes than conventional ultrasound measures of the presence of plaque in the carotid artery.

The researchers assessed 885 people, average age 67, participating in the Rotterdam Study, which includes varying types of imaging to understand better the causes and predictors of dementia and stroke. They utilized computed tomography (CT) scans to measure calcification in four blood vessel areas: the coronary arteries that feed the heart; the aortic arch; and the extracranial and intracranial carotid arteries that carry blood through the neck into the brain.

Researchers used magnetic resonance imaging (MRI) of the brain to visualize small brain infarctions, microbleeds, and bright areas called white matter lesions. White matter in the brain is comprised of the fiber tracts that carry data to and from the brain. White matter lesions are more typically seen in patients who have risk factors such as a history of hypertension, diabetes, and high cholesterol. “These subclinical brain changes, apparent on MRI, do not necessarily cause symptoms right away but are frequently seen in patients with stroke or dementia and over the long term may be associated with worse cognitive performance,” Dr. Vernooij said.

Among the study’s findings were (1) that calcium build-up in each of the four arteries scanned was associated with the presence of small brain infarctions and white matter lesions in the brain. (2) No associations were found between microbleeds in the brain and calcification in any of the arteries studied. (3) As predicted, the amount of calcification in vessels closer to the brain--the extracranial and intracranial carotids--had the strongest relationship to MRI markers of vascular brain disease. (4) Lastly, the most prominent associations were found between intracranial carotid calcification and the volume of white matter lesions, and extracranial carotid calcification and brain infarctions.

“The distinction between the impact of calcification in the extracranial and intracranial carotids adds to the current belief that white matter lesions mainly result from disease in smaller intracranial vessels, while brain infarctions are thought to be mainly caused by larger vessel disease,” Dr. Vernooij noted.

The results will be used to further the understanding of how atherosclerosis affects brain function and ultimately the risk of developing dementia and stroke. “We are a long way from using CT-assessed calcification to screen individuals for brain lesions and dementia risk,” Dr. Vernooij said.

Unanswered questions include whether treatment can reduce calcification in blood vessels and whether doing so would improve cognitive health or lower the risk of dementia and stroke. However, if a physician has performed a heart CT scan to evaluate heart attack risk, the findings may provide information that extends beyond the reason for the examination. “Though far away from the brain, calcification in coronary arteries may indicate the presence of subclinical brain disease as well,” Dr. Vernooij stated.

Related Links:

Erasmus Medical Center





Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Hemostatic Agent
HEMOBLAST Bellows
LED Surgical Lamp
ACEMST35/57
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.